Double‑hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report

Zhang,Yan; Wang,Wei; Chen,Tingting

doi:10.3892/ol.2023.13727

Double‑hit primary lymphoma (MYC and BCL2) in the bilateral ovary: A case report

Authors:
- Yan Zhang
- Wei Wang
- Tingting Chen
View Affiliations

Affiliations: Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Department of Pathology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: February 22, 2023 https://doi.org/10.3892/ol.2023.13727
Article Number: 141
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lymphoid neoplasm with 18q21.3/BCL2 and 8q24/MYC translocation to immunoglobulin genes as dual‑hit lymphoma in female bilateral ovaries is rare and has a poor clinical outcome. The present study reported on the case of a 33‑year‑old female, who was admitted to the hospital due to lower abdominal distension aggravated during defecation but with no obvious inducement. The B‑ultrasound revealed bilateral adnexal solid masses and the pathological examination indicated advanced B‑cell lymphoma (HGBL) with MYC and BCL2 gene rearrangement. The patient then received R‑CHOP treatment, but the effects were poor. Rare extranodal HGBL presentations with MYC and BCL2 rearrangement should be considered in the differential diagnosis of masses at unusual sites, such as the adnexa. Due to their aggressive nature, early and prompt recognition of these lymphomas is essential for appropriately administering therapies.

View Figures

View References

1	Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD and Jaffe ES: The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 127:2375–2390. 2016. View Article : Google Scholar : PubMed/NCBI
2	Elharroudi T, Ismaili N, Errihani H and Jalil A: Primary lymphoma of the ovary. J Cancer Res Ther. 4:195–196. 2008. View Article : Google Scholar : PubMed/NCBI
3	Salam DSDA, Thit EE, Teoh SH, Tan SY, Peh SC and Cheah SC: C-MYC, BCL2 and BCL6 translocation in B-cell non-Hodgkin lymphoma cases. J Cancer. 11:190–198. 2020. View Article : Google Scholar : PubMed/NCBI
4	Nasioudis D, Kampaktsis PN, Frey M, Witkin SS and Holcomb K: Primary lymphoma of the female genital tract: An analysis of 697 cases. Gynecol Oncol. 145:305–309. 2017. View Article : Google Scholar : PubMed/NCBI
5	Ng SP, Leong CF, Nurismah MI, Shahila T and Jamil MA: Primary Burkitt lymphoma of the ovary. Med J Malaysia. 61:363–365. 2006.PubMed/NCBI
6	Crasta JA and Vallikad E: Ovarian lymphoma. Indian J Med Paediatr Oncol. 30:28–30. 2009. View Article : Google Scholar : PubMed/NCBI
7	Zhang H, Lui F and Chen Y: A case of primary ovary non-Hodgkin's malignant lymphoma. Hunan Yi Ke Da Xue Xue Bao. 23:5161998.(In Chinese). PubMed/NCBI
8	Fox H, Langley FA, Govan AD, Hill AS and Bennett MH: Malignant lymphoma presenting as an ovarian tumour: A clinicopathological analysis of 34 cases. Br J Obstet Gynaecol. 95:386–390. 1988. View Article : Google Scholar : PubMed/NCBI
9	Sarina SJ and Song J: A case report and literature review of ‘double strike’ ovarian diffuse large b-fine. Gold lymphoma. Chin J PractGynecol Obstet. 38:247–249. 2022.
10	Wei XX, Zhao Q, Li DP and Huang YH: Recent advances in diagnosis and treatment of double strike lymphoma. J Exp Hematol. 27:1311–1315. 2019.
11	Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, et al: Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget. 7:38122–38132. 2016. View Article : Google Scholar : PubMed/NCBI
12	Sehn LH and Salles G: Diffuse large B-cell lymphoma. N Engl J Med. 384:842–858. 2021. View Article : Google Scholar : PubMed/NCBI
13	Zhuang Y, Che J, Wu M, Guo Y, Xu Y, Dong X and Yang H: Altered pathways and targeted therapy in double hit lymphoma. J Hematol Oncol. 15:262022. View Article : Google Scholar : PubMed/NCBI
14	D'Angelo CR, Hanel W, Chen Y, Yu M, Yang D, Guo L, Karmali R, Burkart M, Ciccosanti C, David K, et al: Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis. Hematol Oncol. 39:473–482. 2021. View Article : Google Scholar : PubMed/NCBI
15	Savage KJ, Johnson NA, Ben-Neriah S, Connors JM, Sehn LH, Farinha P, Horsman DE and Gascoyne RD: MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood. 114:3533–3537. 2009. View Article : Google Scholar : PubMed/NCBI